Fierce Pharma

DECEMBER 8, 2023

Alongside a historic approval for the first therapy utilizing the Nobel Prize-winning CRISPR/Cas9 gene-editing technology, the FDA has cleared a rival gene replacement therapy, also for sickle cell | Alongside a historic approval for the first therapy utilizing the Nobel Prize-winning CRISPR/Cas9 gene-editing technology, the FDA has cleared a rival gene replacement therapy, also for sickle cell disease (SCD).

FDA 344

FDA 344

MedCity News

DECEMBER 8, 2023

This week, two bipartisan members of the Senate Budget Committee launched an investigation into private equity and its impact on healthcare. They initiated the probe to get answers about “questionable financial transactions” that could be hurting care quality for patients at hospitals owned by private equity firms.

Healthcare 129

Healthcare Healthcare Patients Prospecting 129

Fierce Pharma

DECEMBER 8, 2023

Groundbreaking? Game-changing? Transformational? Historic? | Vertex Pharmaceuticals and CRISPR Therapeutics have won an historic FDA approval for their sickle cell disease gene therapy Casgevy. The transformational treatment is a potential cure for the debilitating and life-threatening disease which affects more than 100,000 in the United States, most of them Black.

FDA 325

FDA Medicine Pharmaceutical 325

MedCity News

DECEMBER 8, 2023

Looking back 20 years, when fewer than 18% of physician practices used electronic health records, few experts would have anticipated how information technology has changed healthcare. Thanks to IT, the volume and types of data generated and the speed at which they can be analyzed are vastly different than decades ago.

Healthcare 129

Healthcare Healthcare Electronics Physicians 129

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

DECEMBER 8, 2023

Three years on, Bristol Myers Squibb is bidding adieu to its top dealmaker. | Three years on, Bristol Myers Squibb is bidding adieu to its top dealmaker. Elizabeth Mily, who replaced BMS’ former M&A czar Paul Biondi back in 2020, is headed for the exit, the company confirmed Friday.

325

325

MedCity News

DECEMBER 8, 2023

To help keep participants engaged, and on trial, payment and reimbursement systems should offer the same level of flexibility that people have come to expect in every other walk of life.

Biopharma 124

Biopharma 124

pharmaphorum

DECEMBER 8, 2023

PharmStars digital health accelerator names fall 2023 grads Phil.

122

122

MedCity News

DECEMBER 8, 2023

Prescriptions for GLP-1s are soaring, but fewer than a third of people prescribed the costly drugs will continue taking them one year later without personalized support. Without the expert guidance of a registered dietitian, you risk not achieving the significant clinical benefits these drugs offer and forfeiting the potential for sustainable, transformative health outcomes.

Prescription 119

Prescription Biopharma 119

pharmaphorum

DECEMBER 8, 2023

Africa-led HIV vaccine trial ends in failure Phil.

116

116

MedCity News

DECEMBER 8, 2023

The first gene therapies for sickle cell disease are now approved: Casgevy from Vertex Pharmaceuticals Casgevy and Lyfgenia from Bluebird Bio. Despite the same-day approval, key differences give one of these therapies commercialization advantages over the other.

FDA 119

FDA Pharmaceutical Biopharma Pharma 119

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

PharmExec

DECEMBER 8, 2023

FDA approval of bluebird bio’s Lyfgenia and Vertex Pharmaceuticals' and CRISPR Therapeutics’ Casgevy marks significant milestone in the treatment of sickle cell disease.

FDA 115

FDA Pharmaceutical 115

MedCity News

DECEMBER 8, 2023

Check out news from FreezeNit, Vascular Perfusion Solutions, Kandu, and BetterYou.

Healthcare 111

Healthcare Healthcare 111

PharmaTimes

DECEMBER 8, 2023

One-third of patients who received Pfizer’s COVID-19 vaccine had unintended immune responses - News - PharmaTimes

Patients 110

Patients 110

European Pharmaceutical Review

DECEMBER 8, 2023

AbbVie has signed a definitive agreement to acquire Cerevel Therapeutics and its neuroscience pipeline – including antipsychotic emraclidine – for approximately $8.7 billion. Cerevel’s pipeline includes multiple clinical-stage and preclinical candidates with potential across several diseases including schizophrenia, Parkinson’s disease, and mood disorders.

Safety 105

Safety FDA Management Pharmaceutical 105

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

DECEMBER 8, 2023

Spyre raises $180m to advance IBD antibody pipeline Phil.

105

105

Pharmaceutical Commerce

DECEMBER 8, 2023

Study analyzes and predicts how conditions in research and development can be predicted via computer simulation.

Pharmaceutical 104

Pharmaceutical 104

pharmaphorum

DECEMBER 8, 2023

The US FDA has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.

FDA 104

FDA Pharmaceutical 104

PharmaTimes

DECEMBER 8, 2023

The project will explore the biology of human autoreactive plasma cells - News - PharmaTimes

103

103

Advertisement

MedCity News

DECEMBER 8, 2023

As healthcare IT undergoes continual evolution, the integration of automation and human connection is poised to define the trajectory of IT support. This synergy promises a smooth experience for users and ultimately contributes to enhanced patient care.

Healthcare 101

Healthcare Healthcare Patients 101

Copyright Clearance Center

DECEMBER 8, 2023

AAP responded to tech industry assertions that respect for copyright is an obstacle to their innovation by labeling that as, “nonsense.

98

98

Pharmaceutical Technology

DECEMBER 8, 2023

The newly announced plans would allow third parties to manufacture such drugs if manufacturers make them unaffordable.

Manufacturing 98

Manufacturing 98

European Pharmaceutical Review

DECEMBER 8, 2023

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorised diabetes medicine, Mounjaro (tirzepatide), for weight loss and weight management in adults aged 18 and over. Mounjaro is now authorised for adults with a BMI of 30kg/m² or more (obesity), as well as those with a BMI between 27-30kg/m² (overweight) who also have weight-related health problems eg, prediabetes, high blood pressure, high cholesterol, or heart problems.

Management 98

Management Medicine Food Healthcare 98

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmaTech

DECEMBER 8, 2023

This collaboration will combine BigHat Biosciences’ AI/ML-guided Milliner platform with AbbVie's expertise in oncology and neuroscience to develop next-generation antibodies.

97

97

Pharmaceutical Technology

DECEMBER 8, 2023

Pfizer has added the EU to its growing number of markets for its targeted immunotherapy intended for relapsed/refractory multiple myeloma.

Marketing 96

Marketing 96

PharmaVoice

DECEMBER 8, 2023

A look at the fast-evolving pipeline for gene editing therapies.

FDA 72

FDA 72

pharmaphorum

DECEMBER 8, 2023

Regeneron bids to join the BCMA bispecific camp Phil.

64

64

Advertisement

Distribution

Pharmacy Times

DECEMBER 8, 2023

Psychological safety substantially contributes to team effectiveness, learning, employee retention, and—most critically—better decisions and better performance.

Safety 64

Safety 64

PharmExec

DECEMBER 8, 2023

Farbman discusses the struggles that pharma companies are facing when trying to raise funds and how this is impacting IPOs.

Marketing 59

Marketing Pharma 59

Pharmacy Times

DECEMBER 8, 2023

This FDA approval represents the first cell-based gene therapies for the treatment of sickle cell disease in patients 12 years of age and older.

FDA 59

FDA Patients 59

PharmExec

DECEMBER 8, 2023

Pharma companies must embrace the future to advance commercialization.

Doctors 59

Doctors Patients Pharma 59

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales